Beauty Health EBITDA Margin 2020-2025 | SKIN
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Beauty Health (SKIN) over the last 10 years. The current EBITDA margin for Beauty Health as of September 30, 2025 is .
| Beauty Health EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-09-30 | $0.30B | $0.00B | 0.66% |
| 2025-06-30 | $0.31B | $-0.01B | -3.87% |
| 2025-03-31 | $0.32B | $-0.03B | -8.67% |
| 2024-12-31 | $0.33B | $-0.03B | -8.98% |
| 2024-09-30 | $0.35B | $-0.04B | -10.63% |
| 2024-06-30 | $0.37B | $-0.10B | -27.05% |
| 2024-03-31 | $0.39B | $-0.09B | -22.70% |
| 2023-12-31 | $0.40B | $-0.09B | -23.17% |
| 2023-09-30 | $0.40B | $-0.08B | -20.10% |
| 2023-06-30 | $0.39B | $0.00B | -1.03% |
| 2023-03-31 | $0.38B | 0 | 0.00% |
| 2022-12-31 | $0.37B | $0.00B | 0.55% |
| 2022-09-30 | $0.35B | $-0.01B | -1.73% |
| 2022-06-30 | $0.33B | $-0.01B | -3.08% |
| 2022-03-31 | $0.29B | $-0.03B | -11.11% |
| 2021-12-31 | $0.26B | $-0.02B | -6.90% |
| 2021-06-30 | $0.15B | $-0.01B | -4.67% |
| 2021-03-31 | $0.10B | $0.01B | 5.15% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.193B | $0.334B |
| The Beauty Health Company is a beauty health company. Its flagship brand HydraFacial is a non-invasive and approachable beauty health platform and ecosystem with a powerful community of estheticians, consumers and partners, bridging medical and consumer retail to democratize and personalize skin care solutions for the masses. The Beauty Health Company, formerly known as Vesper Healthcare Acquisition Corp., is based in CHICAGO, Utah. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $168.818B | 31.00 |
| HCA Healthcare (HCA) | United States | $108.237B | 17.92 |
| CVS Health (CVS) | United States | $102.012B | 11.73 |
| Elevance Health (ELV) | United States | $83.333B | 12.22 |
| Cencora (COR) | United States | $66.377B | 21.40 |
| Natera (NTRA) | United States | $32.568B | 0.00 |
| DiDi Global (DIDIY) | China | $23.956B | 22.13 |
| Labcorp Holdings (LH) | United States | $20.757B | 15.83 |
| Medpace Holdings (MEDP) | United States | $16.879B | 41.90 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $16.455B | 0.00 |
| BioMerieux (BMXMF) | France | $15.505B | 0.00 |
| Solventum (SOLV) | United States | $14.863B | 14.43 |
| Viatris (VTRS) | United States | $14.604B | 5.44 |
| ICON (ICLR) | Ireland | $14.548B | 14.44 |
| Revvity (RVTY) | United States | $11.779B | 21.69 |
| CochLear (CHEOY) | Australia | $11.666B | 0.00 |
| Charles River Laboratories (CRL) | United States | $10.769B | 20.74 |
| Avantor (AVTR) | United States | $8.373B | 12.79 |
| Sonic Healthcare (SKHHY) | Australia | $7.695B | 0.00 |
| HealthEquity (HQY) | United States | $7.224B | 27.02 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.223B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $7.036B | 41.95 |
| PACS (PACS) | United States | $6.501B | 39.53 |
| Bausch + Lomb (BLCO) | Canada | $6.199B | 40.70 |
| Sotera Health (SHC) | United States | $5.395B | 26.01 |
| Alignment Healthcare (ALHC) | United States | $4.258B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.719B | 21.70 |
| GeneDx Holdings (WGS) | United States | $3.447B | 60.53 |
| Concentras Parent (CON) | United States | $2.642B | 16.49 |
| Progyny (PGNY) | United States | $2.450B | 48.17 |
| Organon (OGN) | United States | $2.111B | 2.22 |
| Surgery Partners (SGRY) | United States | $2.106B | 27.13 |
| Pediatrix Medical (MD) | United States | $1.946B | 11.62 |
| Establishment Labs Holdings (ESTA) | United States | $1.940B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.287B | 0.00 |
| Nutex Health (NUTX) | United States | $1.278B | 9.77 |
| Ardent Health (ARDT) | United States | $1.269B | 4.14 |
| CareDx (CDNA) | United States | $1.058B | 17.29 |
| GoodRx Holdings (GDRX) | United States | $0.978B | 16.00 |
| Omada Health (OMDA) | United States | $0.933B | 0.00 |
| Embecta (EMBC) | United States | $0.761B | 4.33 |
| InnovAge Holding (INNV) | United States | $0.754B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.672B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.602B | 0.00 |
| CryoPort (CYRX) | United States | $0.533B | 0.00 |
| Enhabit (EHAB) | United States | $0.516B | 23.16 |
| Strata Critical Medical (SRTA) | United States | $0.500B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| SBC Medicals (SBC) | United States | $0.459B | 8.43 |
| Agilon Health (AGL) | United States | $0.409B | 0.00 |
| Oncology Institute (TOI) | United States | $0.379B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.358B | 75.29 |
| Auna S.A (AUNA) | Luxembourg | $0.355B | 5.70 |
| Shoulder Innovations (SI) | United States | $0.292B | 0.00 |
| So-Young (SY) | China | $0.278B | 0.00 |
| KindlyMD (NAKA) | United States | $0.203B | 0.00 |
| LifeMD (LFMD) | United States | $0.202B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.144B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.139B | 0.00 |
| DocGo (DCGO) | United States | $0.088B | 0.00 |
| Biodesix (BDSX) | United States | $0.064B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.062B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.046B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.045B | 0.00 |
| Pomdoctor - (POM) | China | $0.032B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.020B | 6.24 |
| Intelligent Bio Solutions (INBS) | United States | $0.019B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.018B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.012B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.012B | 0.00 |
| Lifeward (LFWD) | United States | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.003B | 0.00 |
| XWELL (XWEL) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.000B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |